Drug Trial Radar · NCT07138196
A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease
Last checked: Nov 19, 2026Latest source record: Dec 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Dec 23, 2025
Primary completion
Oct 23, 2029
Study completion Oct 31, 2029
Sponsor
- Lead sponsor
- Qurient Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open-label, dose escalation study to evaluate safety, tolerability pharmacokinetic and pharmacodynamic activity, and efficacy of Adrixetinib (Q702) in subjects with relapsed or refractory active chronic graft-versus-host disease (cGVHD).
Conditions
- Chronic Graft-Versus-Host Disease
Interventions
AdrixetinibDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Dose-Limiting Toxicities (DLTs)Time frame: Cycle 1 (28 Days)
- Number of Participants with Adverse Event(s) (AEs) and Serious Adverse Event(s) (SAEs)Time frame: Cycle 1 (28 Days)
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Hospital Clinic de Barcelona
Barcelona, Spain · Recruiting
Hospital General Universitario Gregorio Maranon
Madrid, Spain · Recruiting
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Spain · Recruiting
Hospital Universitario Virgen de la Arrixaca
Murcia, Spain · Recruiting
Clinica Universidad de Navarra
Pamplona, Spain · Recruiting
Hospital Universitario Marques de Valdecilla
Santander, Spain · Recruiting
Hospital Universitario Virgen del Rocio
Seville, Spain · Recruiting
Instituto de Investigacion Sanitaria
Valencia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.